Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer.

Diaz-Riascos ZV, Ginesta MM, Fabregat J, Serrano T, Busquets J, Buscail L, Cordelier P, Capellá G.

Mol Ther Nucleic Acids. 2019 Jun 29;17:491-503. doi: 10.1016/j.omtn.2019.06.015. [Epub ahead of print]

2.

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma.

Buscail E, Maulat C, Muscari F, Chiche L, Cordelier P, Dabernat S, Alix-Panabières C, Buscail L.

Cancers (Basel). 2019 Jun 19;11(6). pii: E852. doi: 10.3390/cancers11060852. Review.

3.

Keep Quiet and Stay in Line! Smart Polymers to Keep an Eye on Pancreatic Tumors.

Cordelier P.

Mol Ther. 2018 Apr 4;26(4):940-941. doi: 10.1016/j.ymthe.2018.03.006. Epub 2018 Mar 19. No abstract available.

4.

Spatial Analysis of Nanofluidic-Embedded Biosensors for Wash-Free Single-Nucleotide Difference Discrimination.

Cacheux J, Brut M, Bancaud A, Cordelier P, Leïchlé T.

ACS Sens. 2018 Mar 23;3(3):606-611. doi: 10.1021/acssensors.7b00667. Epub 2018 Mar 1.

PMID:
29437385
5.

CRISPR/Cas9: Transcending the Reality of Genome Editing.

Chira S, Gulei D, Hajitou A, Zimta AA, Cordelier P, Berindan-Neagoe I.

Mol Ther Nucleic Acids. 2017 Jun 16;7:211-222. doi: 10.1016/j.omtn.2017.04.001. Epub 2017 Apr 8. Review.

6.

Proper sister chromatid disjunction requires CDA and PARP-1.

Hoffmann JS, Cordelier P.

Cell Cycle. 2017 Jul 3;16(13):1239-1240. doi: 10.1080/15384101.2017.1326767. Epub 2017 Jun 9. No abstract available.

7.

Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.

Rouanet M, Lebrin M, Gross F, Bournet B, Cordelier P, Buscail L.

Int J Mol Sci. 2017 Jun 8;18(6). pii: E1231. doi: 10.3390/ijms18061231. Review.

8.

Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.

Faccini J, Ruidavets JB, Cordelier P, Martins F, Maoret JJ, Bongard V, Ferrières J, Roncalli J, Elbaz M, Vindis C.

Sci Rep. 2017 Feb 16;7:42916. doi: 10.1038/srep42916.

9.

Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas.

Bournet B, Vignolle-Vidoni A, Grand D, Roques C, Breibach F, Cros J, Muscari F, Carrère N, Selves J, Cordelier P, Buscail L.

Endosc Int Open. 2016 Dec;4(12):E1228-E1235. Epub 2016 Nov 10.

10.

Twelfth Annual Meeting of the French Society of Cell and Gene Therapy.

Verhoeyen E, Gomez S, Galy A, Ayuso E, Midoux P, Pucéat M, Vassaux G, Cordelier P.

Hum Gene Ther. 2016 Jul;27(7):555-8. doi: 10.1089/hum.2016.29031.eve. No abstract available.

PMID:
27428658
11.

Regulating the expression of therapeutic transgenes by controlled intake of dietary essential amino acids.

Chaveroux C, Bruhat A, Carraro V, Jousse C, Averous J, Maurin AC, Parry L, Mesclon F, Muranishi Y, Cordelier P, Meulle A, Baril P, Do Thi A, Ravassard P, Mallet J, Fafournoux P.

Nat Biotechnol. 2016 Jul;34(7):746-51. doi: 10.1038/nbt.3582. Epub 2016 Jun 6.

PMID:
27272383
12.

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma.

Bournet B, Muscari F, Buscail C, Assenat E, Barthet M, Hammel P, Selves J, Guimbaud R, Cordelier P, Buscail L.

Clin Transl Gastroenterol. 2016 Mar 24;7:e157. doi: 10.1038/ctg.2016.18.

13.

REG3β Plays a Key Role in IL17RA Protumoral Effect-Response.

Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI, Chuluyan E, Cordelier P, Dubus P, Lomberk G, Urrutia R, Closa D, Iovanna JL.

Cancer Res. 2016 Apr 1;76(7):2051. doi: 10.1158/0008-5472.CAN-15-3355. Epub 2016 Mar 18. No abstract available.

14.

Hopes, Promises, and Future Directions of Gene and Cell Therapies in France.

Cartier N, Cordelier P.

Hum Gene Ther. 2016 Feb;27(2):96-7. doi: 10.1089/hum.2016.29020.nca. Review. No abstract available.

PMID:
26886830
15.

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.

Bournet B, Buscail C, Muscari F, Cordelier P, Buscail L.

Eur J Cancer. 2016 Feb;54:75-83. doi: 10.1016/j.ejca.2015.11.012. Epub 2015 Dec 28. Review.

PMID:
26735353
16.

Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.

Hanoun N, Gayral M, Pointreau A, Buscail L, Cordelier P.

Hum Gene Ther. 2016 Feb;27(2):184-92. doi: 10.1089/hum.2015.151.

17.

The Promise of Gene Therapy for Pancreatic Cancer.

Vassaux G, Angelova A, Baril P, Midoux P, Rommelaere J, Cordelier P.

Hum Gene Ther. 2016 Feb;27(2):127-33. doi: 10.1089/hum.2015.141. Review.

PMID:
26603492
18.

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.

Ligat L, Saint-Laurent N, El-Mrani A, Gigoux V, Al Saati T, Tomasini R, Nigri J, Dejean S, Pont F, Baer R, Guillermet-Guibert J, Cordelier P, Lopez F, Dufresne M.

Br J Cancer. 2015 Dec 1;113(11):1590-8. doi: 10.1038/bjc.2015.370. Epub 2015 Oct 29.

19.

IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer.

Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI, Chuluyan E, Cordelier P, Dubus P, Lomberk G, Urrutia R, Closa D, Iovanna JL.

Cancer Res. 2015 Nov 15;75(22):4852-62. doi: 10.1158/0008-5472.CAN-15-0896. Epub 2015 Sep 24.

20.

Salivary MicroRNA in Pancreatic Cancer Patients.

Humeau M, Vignolle-Vidoni A, Sicard F, Martins F, Bournet B, Buscail L, Torrisani J, Cordelier P.

PLoS One. 2015 Jun 29;10(6):e0130996. doi: 10.1371/journal.pone.0130996. eCollection 2015.

Supplemental Content

Loading ...
Support Center